Farzana Jasmine is a staff scientist at the Institute for Population and Precision Health (IPPH), Department of Public Health Sciences (PHS), Biological Sciences Division, University of Chicago. She received an MB,BS from the Institute for Postgraduate Medicine and Research, Dhaka University, in 1987, and a PhD in medicine from the Medical Academy Sofia, Bulgaria, in 1994. She worked as a postdoctoral research fellow at Columbia University, NY (2003–2006). She is trained in medicine, endocrinology, epidemiology, environmental health, and cancer genomics, with research interests in molecular genomics, cancer epidemiology, and the pathogenesis of human cancers, including colorectal, breast, thyroid, and non-melanoma skin cancer. She has worked in GWASs, transcriptomics, DNA methylation, cytogenomic changes in cancer, telomere biology and its implications in cancer, somatic mutation, inflammatory cytokines, and other biomarkers in cancer and metabolic syndrome. She has been involved in multiple large-scale cohorts, like the Health Effects of Arsenic Longitudinal Studies (HEALS), the Bangladesh vitamin E and Selenium Trial (BEST), the ChicagO Multiethnic Prevention And Surveillance Study (COMPASS), and NCI-CONNECT. She has extensive experience in different molecular genomic assays like microarrays (genotyping, gene expression, and DNA methylation), metagenomics, next-generation sequencing on the Illumina platform, and high-throughput assay development on the Luminex platform.